Annals of Emergency Medicine
Volume 49, Issue 2 , Pages 164-171.e1 , February 2007

Patterns of Ecstasy-Associated Hyponatremia in California

  • Jonathan Rosenson, MD

      Affiliations

    • Alameda County Medical Center/Highland General Hospital, Department of Emergency Medicine, Oakland, CA
    • University of California, San Francisco, School of Medicine, San Francisco, CA
    • Corresponding Author InformationAddress for correspondence: Jonathan Rosenson, MD, Department of Emergency Medicine, Alameda County Medical Center, Highland Campus, 1411 E. 31st Street, Oakland, CA 94602; 510-437-4563, fax 510-437-8322
    • ,
  • Craig Smollin, MD

      Affiliations

    • California Poison Control System, San Francisco, CA
    • San Francisco General Hospital, Department of Emergency Services, San Francisco, CA
    • ,
  • Karl A. Sporer, MD

      Affiliations

    • University of California, San Francisco, School of Medicine, San Francisco, CA
    • San Francisco General Hospital, Department of Emergency Services, San Francisco, CA
    • ,
  • Paul Blanc, MD, MSPH

      Affiliations

    • University of California, San Francisco, School of Medicine, San Francisco, CA
    • School of Pharmacy, San Francisco, CA
    • California Poison Control System, San Francisco, CA
    • ,
  • Kent R. Olson, MD

      Affiliations

    • University of California, San Francisco, School of Medicine, San Francisco, CA
    • School of Pharmacy, San Francisco, CA
    • California Poison Control System, San Francisco, CA

Received 3 February 2006 ,Revised 12 September 2006 ,Accepted 21 September 2006.

References 

  1. Shannon M. Methylenedioxymethamphetamine (MDMA, “ecstasy”). Pediatr Emerg Care. 2000;16:377–380
  2. Patel MM, Wright DW, Ratcliff JJ, et al. Shedding new light on the “safe” club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities. Acad Emerg Med. 2004;11:208–210
  3. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet. 1992;340:384–387
  4. Budisavljevic MN, Stewart L, Sahn SA, et al. Hyponatremia associated with 3,4-methylenedioxymethamphetamine (“ecstasy”) abuse. Am J Med Sci. 2003;326:89–93
  5. Hartung TK, Schofield E, Short AI, et al. Hyponatremic states following 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) ingestion. QJM. 2002;95:431–437
  6. White JM, Bochner F, Irvine RJ. The agony of “ecstasy”. Med J Aust. 1997;66:117–118
  7. Sue YM, Lee YL, Huang JJ. Acute hyponatremia, seizure and rhabdomyolysis after ecstasy use. J Toxicol. 2002;40:931–932
  8. Ben-Abraham R, Szold O, Rudick V, et al. Ecstasy intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting. Eur J Emerg Med. 2003;10:309–313
  9. Schwartz RH, Miller NS. MDMA (ecstasy) and the rave: a review. Pediatrics. 1997;100:705–708
  10. Harris DS, Baggott M, Mendelson JH, et al. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology. 2002;162:396–405
  11. Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ. 2001;165:917–928
  12. Screaton GR, Singer M, Cairns HS, et al. Hyperpyrexia and rhabdomyolysis after MDMA (“ecstasy”) abuse. Lancet. 1992;339:677–678
  13. Patel MM, Belson MG, Longwater AB, et al. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. J Emerg Med. 2005;29:451–455
  14. Singarajah C, Lavies NG. An overdose of ecstasy: a role for dantrolene. Anaesthesia. 1992;47:686–687
  15. Burgess C, O’Donohoe A, Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. Eur Psychiatry. 2000;15:287–294
  16. Kwon C, Zaritsky A, Dharnidharka VR. Transient proximal tubular renal injury following ecstasy ingestion. Pediatr Nephrol. 2003;18:820–822
  17. Mueller PD, Korey WS. Death by “ecstasy”: the serotonin syndrome?. Ann Emerg Med. 1998;32:377–380
  18. Maxwell DL, Polkey MI, Henry JA. Hyponatremia and catatonic stupor after taking “ecstasy” [letter]. BMJ. 1993;307:1399
  19. Ajaelo I, Koenig K, Snoey E. Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use. Acad Emerg Med. 1998;5:839–840
  20. Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after ecstasy (3,4-MDMA) [letter]. Lancet. 1996;347:1052
  21. Traub SJ, Hoffman RS, Nelson LS. The “ecstasy” hangover: hyponatremia due to 3 4-methylenedioxymethamphetamine. J Urban Health. 2002;4:549–555
  22. Cherney DZ, Davids MR, Halperin ML. Acute hyponatremia and “ecstasy”: insights from a quantitative and integrative analysis. QJM. 2002;95:475–483
  23. Reneman L, Booij J, de Bruin K, et al. Effects of dose, sex and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet. 2001;358:1864–1869
  24. Toxic Exposure Surveillance System. Instruction for the Toxic Exposure Surveillance System (TESS). Washington, DC: American Association of Poison Control Centers; 2001;
  25. Henry JA, Fallon JK, Kicman AT. Low-dose MDMA (“ecstasy”) induces vasopressin secretion [letter]. Lancet. 1998;351:1784
  26. Brownfield MS, Greathouse J, Lorens SA, et al. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology. 1988;47:277–283
  27. Forsling ML, Stromberg P, Akerlund M. Effect of ovarian steroids on vasopressin secretion. J Endocrinol. 1982;95:147–151
  28. Ayus CJ, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med. 1992;117:891–897
  29. Arieff AI, Kozniewska E, Roberts TP, et al. Age, gender and vasopressin affect survival and brain adaptation in rats with metabolic encephalopathy. Am J Physiol. 1995;268:R1143–R1152
  30. Brvar M, Kozelj G, Osredkar J, et al. Polydipsia as another mechanism of hyponatremia after ecstasy (3,4-methylenedioxymethamphetamine) ingestion. Eur J Emerg Med. 2004;11:302–304
  31. Forsling ML, Fallon JK, Shah D, et al. The effect of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus. Br J Pharm. 2002;135:649–656
  32. Belton K, Thomas SH. Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Postgrad Med J. 1999;75:509–510
  33. McKenna DJ, Peroutka SJ. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). J Neurochem. 1990;54:14–22
  34. Rudnick G, Wall SC. The molecular mechanism of “ecstasy” (3,4-methylenedioxymethamphetamine (MDMA)): serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci U S A. 1992;89:1817–1821
  35. Kundi SA, Forsling M, Kleimestur H, et al. Effect of tamoxifen on pituitary vasopressin level. J Ayub Med Coll Abbottabad. 2004;16:80–83
  36. Stachenfeld NS, Keefe DL. Estrogen effects on osmotic regulation of AVP and fluid balance. Am J Physiol Endocrinol Metab. 2002;283:E711–E721
  37. Wang YX, Crofton JT, Liu H, et al. Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized rats. Am J Physiol. 1995;268:R951–R957
  38. Available at: http://dancesafe.org/documents/druginfo/ecstasy.php. Accessed January 29, 2005.

 Supervising editor: E. Martin Caravati, MD, MPHAuthor contributions: JR, CS, KAS, and KRO conceived the study, designed the trial, and provided data analysis. JR, CS, PB, and KRO coordinated data collection and management. JR, CS, KAS, and KRO obtained University of California, San Francisco Committee on Human Research and California Poison Control System Research Committee approval. JR, CS, PB, and KRO coordinated data management and performed statistical analysis. CS, KAS, PB, and KRO contributed statistical advice. JR drafted the article, and all authors contributed substantially to its revision. KAS and KRO supervised conduct of the study. JR takes responsibility for the paper as a whole.Funding and support: Dr. Blanc was supported in part by DA 14935 (National Institute on Drug Abuse, National Institutes of Health).Reprints not available from the authors.

PII: S0196-0644(06)02273-6

doi: 10.1016/j.annemergmed.2006.09.018

Annals of Emergency Medicine
Volume 49, Issue 2 , Pages 164-171.e1 , February 2007

Article Tools

* Image Usage & Resolution